- ►annals.org AM Kanaya, D Herrington, E Vittinghoff, F Lin, … - Annals of internal medicine, 2003 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Randomized trials of postmenopausal hormone therapy have found ... Cited by 191 - Related articles - BL Direct - All 7 versions
KL Margolis, DE Bonds, RJ Rodabough, L … - Diabetologia, 2004 - Springer Aims/hypothesis. Studies examining the effect of postmenopausal hormone therapy
on concentrations of glucose, insulin and diabetes incidence have been
inconclusive, in part because many of the studies were too small. We ... Cited by 124 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org R Padwal, SR Majumdar, JA Johnson, J … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Ten studies of oral hypoglycemic agents and 15 studies of nonoral
hypoglycemic agents were found. Oral hypoglycemic agents and orlistat are the
only drugs that have been studied in randomized controlled trials with ... Cited by 116 - Related articles - BL Direct - All 12 versions
- ►physiology.org [PDF] RW Mankhey, F Bhatti, C Maric - American Journal of Physiology- Renal Physiology, 2004 - Am Physiological Soc Page 1. 17ß-estradiol replacement improves renal function and pathology
associated with diabetic nephropathy Richard W. Mankhey1 ... Cited by 51 - Related articles - All 6 versions
- ►ahajournals.org BV Howard, J Hsia, P Ouyang, L Van Voorhees … - Circulation, 2004 - Am Heart Assoc Methods and Results— We randomly assigned 423 postmenopausal women with
angiographically defined atherosclerosis (321 women had exit angiograms) with
(n=140) or without (n=181) AGT to receive estrogen, estrogen plus ... Cited by 49 - Related articles - BL Direct - All 5 versions
EN Liberopoulos, S Tsouli, DP Mikhailidis, MS … - Current Drug Targets, 2006 - ingentaconnect.com 1Department of Clinical Biochemistry (Vascular Disease Prevention clinics),
Royal Free Hospital University College School of Medicine (University of
London), London, UK and 2Department of Internal Medicine, School of ... Cited by 48 - Related articles - BL Direct - All 2 versions
IF Godsland - Diabetologia, 2005 - Springer Abstract There is a persistent perception that oestrogens have an adverse effect
on carbohydrate metabolism. It might therefore be expected that their use would
result in a corresponding increase in the incidence of diabetes. Recent ... Cited by 39 - Related articles - BL Direct - All 5 versions
E Barrett-Connor, KE Ensrud, K Harper, TM … - Clinical therapeutics, 2003 - Elsevier Results: At baseline, 202 of all 5133 women (3.9%) had type 2 diabetes. Of the
1800 women who were assessed for HbA 1c , LDL-C, TGs, apo AI, apo B, and
fibrinogen, 70 (3.9%) had type 2 diabetes at baseline. Compared with ... Cited by 28 - Related articles - All 5 versions
R Rossi, G Origliani, MG Modena - Diabetes Care, 2004 - Am Diabetes Assoc OBJECTIVE—Various observational and randomized studies have demonstrated a
reduction in the incidence of type 2 diabetes in postmenopausal women who
received estrogen orally. No studies have been performed on the incidence ... Cited by 27 - Related articles - BL Direct - All 6 versions
P Shah, A Vella, A Basu, R Basu, A Adkins, … - Diabetes, 2003 - Am Diabetes Assoc The present study sought to determine whether elevated plasma free fatty acids
(FFAs) alter the splanchnic and muscle glucose metabolism in women. To do so,
FFAs were increased in seven women by an 8-h Intralipid/heparin (IL/hep) ... Cited by 20 - Related articles - BL Direct - All 5 versions
